subgroup of
vaccine)
→
ReceivesAction
→
marketed to the public
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| for the last several years | 3 | temporal |
| hpv vaccine → be marketed to → the public | 3 |
| negative | neutral | positive |
| 0.294 | 0.661 | 0.045 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 27.900 |